{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:47Z","timestamp":1790713247582,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uterine fibroids are the most common benign uterine tumors and can cause various severe symptoms as abnormal menstrual bleeding or pelvic pain. Therefore, the primary objective in the treatment of uterine fibroids is a sufficient symptom relief. Ultrasound (US)-guided High-intensity focused ultrasound (HIFU) is an effective non-invasive treatment strategy for ablation of uterine fibroids that can achieve a significant tumor volume reduction. The aim of the study is to evaluate if US-guided HIFU treatment can reduce fibroid-associated symptoms leading to an improvement of health-related quality of life. Fifty-five women with symptomatic uterine fibroids underwent US-guided HIFU ablation. Clinical evaluation was performed on the basis of the Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire (UFS-QOL) at baseline, 6\u00a0weeks, 3, 6, 9 and 12\u00a0months after HIFU. Imaging follow-up included contrast-enhanced ultrasound (CEUS) and contrast-enhanced MRI. A significant reduction of the Symptom Severity Scale (SSS) was observed between 6\u00a0weeks and 12\u00a0months after HIFU (49.9\u2009\u00b1\u200919.4 at baseline vs. 42.2\u2009\u00b1\u200920.1 at 6\u00a0weeks and 23.6\u2009\u00b1\u200912.7 at 12\u00a0months after treatment, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) correlating with a significant improvement (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) of Health-related Quality of Life (HRQL) (52.5\u2009\u00b1\u200922.7 at baseline vs. 59.8\u2009\u00b1\u200922 at 6\u00a0weeks and 77.9\u2009\u00b1\u200917.3 at 12\u00a0months after treatment). Significant postinterventional improvement was observed in every subscale of HRQL. In the majority of patients, only minor, short-lasting and self-limiting side effects were observed, e.g. soft tissue edema of the anterior lower abdominal wall in the acoustic pathway or transient moderate lower abdominal pain as during menstruation. One patient with a very large fibroid experienced strong short-lasting pain after the procedure; two patients experienced post-procedurally a transient\u00a0sciatic nerve irritation. US-guided HIFU of uterine fibroids reduces disease-related symptoms and improves health-related quality of life.<\/jats:p>","DOI":"10.1038\/s41598-022-24994-w","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T12:05:55Z","timestamp":1670414755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids"],"prefix":"10.1038","volume":"12","author":[{"given":"Tolga","family":"Tonguc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Recker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Ganslmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger M.","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus C.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ramig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Welz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva K.","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Mutschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Warwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Essler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mustea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milka","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"24994_CR1","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","volume":"124","author":"EA Stewart","year":"2017","unstructured":"Stewart, E. A., Cookson, C. L., Gandolfo, R. A. & Schulze-Rath, R. Epidemiology of uterine fibroids: A systematic review. BJOG 124, 1501\u20131512 (2017).","journal-title":"BJOG"},{"key":"24994_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird, D. D., Dunson, D. B., Hill, M. C., Cousins, D. & Schectman, J. M. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am. J. Obstet. Gynecol. 188, 100\u2013107 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"24994_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6874-12-6","volume":"12","author":"A Zimmermann","year":"2012","unstructured":"Zimmermann, A., Bernuit, D., Gerlinger, C., Schaefers, M. & Geppert, K. Prevalence, symptoms and management of uterine fibroids: An international internet-based survey of 21,746 women. BMC Women\u2019s Health 12, 6 (2012).","journal-title":"BMC Women\u2019s Health"},{"key":"24994_CR4","first-page":"877","volume":"111","author":"AS Boosz","year":"2014","unstructured":"Boosz, A. S., Reimer, P., Matzko, M., R\u00f6mer, T. & M\u00fcller, A. The conservative and interventional treatment of fibroids. Dtsch. Arztebl. Int. 111, 877\u2013883 (2014).","journal-title":"Dtsch. Arztebl. Int."},{"key":"24994_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/humupd\/dmw023","volume":"22","author":"J Donnez","year":"2016","unstructured":"Donnez, J. & Dolmans, M.-M. Uterine fibroid management: From the present to the future. Hum. Reprod. Update 22, 665\u2013686 (2016).","journal-title":"Hum. Reprod. Update"},{"key":"24994_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0037-1607264","volume":"35","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy, A., Myers, E. R. & Stewart, E. Uterine fibroids: Burden and unmet medical need. Semin. Reprod. Med. 35, 473\u2013480 (2017).","journal-title":"Semin. Reprod. Med."},{"key":"24994_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","volume":"22","author":"S Gupta","year":"2008","unstructured":"Gupta, S., Jose, J. & Manyonda, I. Clinical presentation of fibroids. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 615\u2013626 (2008).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"24994_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/IJWH.S138982","volume":"9","author":"A Mas","year":"2017","unstructured":"Mas, A. et al. Updated approaches for management of uterine fibroids. Int. J. Womens Health 9, 607\u2013617 (2017).","journal-title":"Int. J. Womens Health"},{"key":"24994_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149631","volume":"11","author":"KS Gurusamy","year":"2016","unstructured":"Gurusamy, K. S., Vaughan, J., Fraser, I. S., Best, L. M. J. & Richards, T. Medical therapies for uterine fibroids - A systematic review and network meta-analysis of randomised controlled trials. PLoS ONE 11, e0149631 (2016).","journal-title":"PLoS ONE"},{"key":"24994_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/uog.7455","volume":"34","author":"K Funaki","year":"2009","unstructured":"Funaki, K., Fukunishi, H. & Sawada, K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet. Gynecol. 34, 584\u2013589 (2009).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"24994_CR11","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00330-012-2517-z","volume":"22","author":"W Wang","year":"2012","unstructured":"Wang, W. et al. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids. Eur. Radiol. 22, 2553\u20132558 (2012).","journal-title":"Eur. Radiol."},{"issue":"Suppl 2","key":"24994_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0015-0282(03)00783-0","volume":"80","author":"A Keshavarzi","year":"2003","unstructured":"Keshavarzi, A., Vaezy, S., Noble, M. L., Paun, M. K. & Fujimoto, V. Y. Treatment of uterine fibroid tumors in an in situ rat model using high-intensity focused ultrasound. Fertil. Steril. 80(Suppl 2), 761\u2013767 (2003).","journal-title":"Fertil. Steril."},{"key":"24994_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ultrasmedbio.2008.12.006","volume":"35","author":"JH Hwang","year":"2009","unstructured":"Hwang, J. H. et al. Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med. Biol. 35, 967\u2013975 (2009).","journal-title":"Ultrasound Med. Biol."},{"key":"24994_CR14","doi-asserted-by":"publisher","first-page":"W245","DOI":"10.2214\/AJR.09.3321","volume":"195","author":"F Orsi","year":"2010","unstructured":"Orsi, F. et al. High-intensity focused ultrasound ablation: Effective and safe therapy for solid tumors in difficult locations. Am. J. Roentgenol. 195, W245\u2013W252 (2010).","journal-title":"Am. J. Roentgenol."},{"key":"24994_CR15","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1007\/s00330-016-4239-0","volume":"26","author":"M Marinova","year":"2016","unstructured":"Marinova, M. et al. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: Evaluation of feasibility, reduction of tumour volume and pain intensity. Eur. Radiol. 26, 4047\u20134056 (2016).","journal-title":"Eur. Radiol."},{"key":"24994_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.diii.2018.03.001","volume":"99","author":"IAS Elhelf","year":"2018","unstructured":"Elhelf, I. A. S. et al. High intensity focused ultrasound: The fundamentals, clinical applications and research trends. Diagn. Interv. Imaging 99, 349\u2013359 (2018).","journal-title":"Diagn. Interv. Imaging"},{"key":"24994_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2214\/ajr.183.6.01831713","volume":"183","author":"J Hindley","year":"2004","unstructured":"Hindley, J. et al. MRI guidance of focused ultrasound therapy of uterine fibroids: Early results. AJR Am. J. Roentgenol. 183, 1713\u20131719 (2004).","journal-title":"AJR Am. J. Roentgenol."},{"key":"24994_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.fertnstert.2005.04.072","volume":"85","author":"EA Stewart","year":"2006","unstructured":"Stewart, E. A. et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil. Steril. 85, 22\u201329 (2006).","journal-title":"Fertil. Steril."},{"key":"24994_CR19","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1016\/j.ejrad.2012.04.030","volume":"81","author":"S Peng","year":"2012","unstructured":"Peng, S. et al. Clinical utility of a microbubble-enhancing contrast (\u201cSonoVue\u201d) in treatment of uterine fibroids with high intensity focused ultrasound: A retrospective study. Eur. J. Radiol. 81, 3832\u20133838 (2012).","journal-title":"Eur. J. Radiol."},{"key":"24994_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jmig.2013.09.004","volume":"21","author":"F Wang","year":"2014","unstructured":"Wang, F. et al. Ultrasound-guided high-intensity focused ultrasound versus laparoscopic myomectomy for symptomatic uterine myomas. J. Minim. Invasive Gynecol. 21, 279\u2013284 (2014).","journal-title":"J. Minim. Invasive Gynecol."},{"key":"24994_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1754-9485.2012.02376.x","volume":"56","author":"A Dobrotwir","year":"2012","unstructured":"Dobrotwir, A. & Pun, E. Clinical 24 months experience of the first MRgFUS unit for treatment of uterine fibroids in Australia. J. Med. Imaging Radiat. Oncol. 56, 409\u2013416 (2012).","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"24994_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jmig.2008.06.010","volume":"15","author":"H Fukunishi","year":"2008","unstructured":"Fukunishi, H. et al. Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: Analysis of 20 cases. J. Minim. Invasive Gynecol. 15, 571\u2013579 (2008).","journal-title":"J. Minim. Invasive Gynecol."},{"key":"24994_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7863\/jum.2007.26.2.201","volume":"26","author":"X-L Ren","year":"2007","unstructured":"Ren, X.-L. et al. Extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: Imaging and histopathologic evaluation. J. Ultrasound Med. 26, 201\u2013212 (2007).","journal-title":"J. Ultrasound Med."},{"key":"24994_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1477-7525-6-99","volume":"6","author":"G Harding","year":"2008","unstructured":"Harding, G., Coyne, K. S., Thompson, C. L. & Spies, J. B. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual. Life Outcomes 6, 99 (2008).","journal-title":"Health Qual. Life Outcomes"},{"key":"24994_CR25","first-page":"290","volume":"99","author":"JB Spies","year":"2002","unstructured":"Spies, J. B. et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet. Gynecol. 99, 290\u2013300 (2002).","journal-title":"Obstet. Gynecol."},{"key":"24994_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s42155-019-0080-2","volume":"2","author":"VAV Fornazari","year":"2019","unstructured":"Fornazari, V. A. V. et al. Impact of uterine contractility on quality of life of women undergoing uterine fibroid embolization. CVIR Endovasc. 2, 36 (2019).","journal-title":"CVIR Endovasc."},{"key":"24994_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jval.2012.03.1387","volume":"15","author":"KS Coyne","year":"2012","unstructured":"Coyne, K. S., Margolis, M. K., Murphy, J. & Spies, J. Validation of the UFS-QOL-hysterectomy questionnaire: Modifying an existing measure for comparative effectiveness research. Value Health 15, 674\u2013679 (2012).","journal-title":"Value Health"},{"key":"24994_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/03007995.2016.1248382","volume":"33","author":"KS Coyne","year":"2017","unstructured":"Coyne, K. S., Soliman, A. M., Margolis, M. K., Thompson, C. L. & Chwalisz, K. Validation of the 4 week recall version of the uterine fibroid symptom and health-related quality of life (UFS-QOL) questionnaire. Curr. Med. Res. Opin. 33, 193\u2013200 (2017).","journal-title":"Curr. Med. Res. Opin."},{"key":"24994_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s41687-019-0146-x","volume":"3","author":"KS Coyne","year":"2019","unstructured":"Coyne, K. S. et al. Psychometric validation of the 1-month recall uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). J. Patient Rep. Outcomes 3, 57 (2019).","journal-title":"J. Patient Rep. Outcomes"},{"key":"24994_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08156-6","author":"L Liu","year":"2021","unstructured":"Liu, L., Wang, T. & Lei, B. High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: A meta-analysis. Eur. Radiol. https:\/\/doi.org\/10.1007\/s00330-021-08156-6 (2021).","journal-title":"Eur. Radiol."},{"key":"24994_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/1471-0528.14689","volume":"125","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: An IDEAL prospective exploration study. BJOG 125, 354\u2013364 (2018).","journal-title":"BJOG"},{"key":"24994_CR32","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ultrasmedbio.2020.02.018","volume":"46","author":"L Hu","year":"2020","unstructured":"Hu, L. et al. Comparison of focused ultrasound surgery and hysteroscopic resection for treatment of submucosal uterine fibroids (FIGO Type 2). Ultrasound Med. Biol. 46, 1677\u20131685 (2020).","journal-title":"Ultrasound Med. Biol."},{"key":"24994_CR33","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/1471-0528.16262","volume":"127","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: A retrospective study. BJOG 127, 1422\u20131428 (2020).","journal-title":"BJOG"},{"key":"24994_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/02656736.2020.1774081","volume":"37","author":"G Wu","year":"2020","unstructured":"Wu, G. et al. A comparison of the pregnancy outcomes between ultrasound-guided high-intensity focused ultrasound ablation and laparoscopic myomectomy for uterine fibroids: A comparative study. Int. J. Hyperth. 37, 617\u2013623 (2020).","journal-title":"Int. J. Hyperth."},{"key":"24994_CR35","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.acra.2011.03.008","volume":"18","author":"HS Kim","year":"2011","unstructured":"Kim, H. S., Baik, J.-H., Pham, L. D. & Jacobs, M. A. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: Long-term outcomes. Acad. Radiol. 18, 970\u2013976 (2011).","journal-title":"Acad. Radiol."},{"key":"24994_CR36","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1007\/s00330-013-2915-x","volume":"23","author":"ME Ikink","year":"2013","unstructured":"Ikink, M. E. et al. Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids. Eur. Radiol. 23, 3054\u20133061 (2013).","journal-title":"Eur. Radiol."},{"key":"24994_CR37","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1080\/02656736.2017.1421323","volume":"34","author":"M He","year":"2018","unstructured":"He, M., Jacobson, H., Zhang, C., Setzen, R. & Zhang, L. A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa. Int. J. Hyperth. 34, 1304\u20131310 (2018).","journal-title":"Int. J. Hyperth."},{"key":"24994_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jmig.2017.01.010","volume":"24","author":"JE Parsons","year":"2017","unstructured":"Parsons, J. E. et al. Pilot study of the mirabilis system prototype for rapid noninvasive uterine Myoma treatment using an ultrasound-guided volumetric shell ablation technique. J. Minim. Invasive Gynecol. 24, 579\u2013591 (2017).","journal-title":"J. Minim. Invasive Gynecol."},{"key":"24994_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ultsonch.2015.05.033","volume":"27","author":"J-S Lee","year":"2015","unstructured":"Lee, J.-S., Hong, G.-Y., Park, B.-J. & Kim, T.-E. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid and adenomyosis: A single center experience from the Republic of Korea. Ultrason. Sonochem. 27, 682\u2013687 (2015).","journal-title":"Ultrason. Sonochem."},{"key":"24994_CR40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.fertnstert.2015.11.014","volume":"105","author":"VL Jacoby","year":"2016","unstructured":"Jacoby, V. L. et al. PROMISe trial: A pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil. Steril. 105, 773\u2013780 (2016).","journal-title":"Fertil. Steril."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24994-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24994-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24994-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T12:14:11Z","timestamp":1670415251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24994-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24994"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24994-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"24 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21155"}}